drugset / Trial / NCT03772223

A Study to Compare the Pharmacokinetics of Budesonide and Albuterol Delivered by PT027 Compared With PT007 and PT008 Administered Separately.

NCT03772223

Phase 1 Completed 91 enrolled AstraZeneca
RandomizedCrossoverOpen-labelTreatment

Summary

This is a Phase 1 study to compare the pharmacokinetics of budesonide and albuterol delivered by PT027 compared with PT007 and PT008 administered separately.

Timeline

Start
2019-01-21
Primary completion
2019-05-10
Completion
2019-05-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 80 ug Inhaled
Subject Salbutamol Unknown 90 ug Inhaled

Indications

No indication recorded.